TFP
ELV icon

Tilia Fiduciary Partners’s Elevance Health ELV Stock Holding History

Tilia Fiduciary Partners’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-180
Closed -$80K – 208
2023
Q2 		$80K Sell
180
-26
-13% -$12K 0.07% 157
2023
Q1 		$94.7K Sell
206
-5
-2% -$2.38K 0.09% 143
2022
Q4 		$108K Sell
211
-5
-2% -$2.54K 0.1% 134
2022
Q3 		$102K Sell
216
-9
-4% -$4.31K 0.1% 136
2022
Q2 		$108K Buy
225
+45
+25% +$22.3K 0.1% 133
2022
Q1 		$88K Hold
180
– – 0.07% 162
2021
Q4 		$83K Buy
+180
New +$75.7K 0.07% 170

Other funds holding ELV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Sanders Capital
Sanders Capital West Palm Beach, Florida $83.9B AUM 37.89% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Tilia Fiduciary Partners's ELV Position: Q3 2023 in Review

Tilia Fiduciary Partners sold out of Elevance Health (ELV) in Q3 2023, closing a stake of 180 shares — an estimated $80K sold.

Tilia Fiduciary Partners first reported a position in ELV in Q4 2021 and held it in 7 quarters. The position peaked at $108K in Q4 2022. 1,524 funds tracked by Wall St. Rank hold ELV as of Q3 2023.

  • Tilia Fiduciary Partners reported no remaining Elevance Health position as of Q3 2023 after selling out during the quarter.
  • Tilia Fiduciary Partners sold 180 Elevance Health shares in Q3 2023, an estimated $80K.
  • Tilia Fiduciary Partners first reported a position in Elevance Health in Q4 2021 and held it in 7 quarters.
  • Tilia Fiduciary Partners's Elevance Health position peaked at $108K in Q4 2022.
  • 1,524 funds tracked by Wall St. Rank held Elevance Health as of Q3 2023.

Based on Tilia Fiduciary Partners's 13F filing for Q3 2023, filed 10 Oct 2023.